When Gabe Otte went to college, he already had an Apple internship under his belt. In undergrad, his computer-science professors told him to diversify and pick out another area to focus on so he wasn’t bored in class, so he chose biology.
Innovation is the foundation of the 21st Century bioscience industry. It is an industry borne from scientific innovations involving techniques to understand and manage the machinery of living things. The advent of biotechnology in the 1970s, enabled work at the molecular and cellular level including moving genetic information from one living cell to another and tracing the pathways of disease. Over the last 40 years, bioscience innovation has advanced at an astonishing speed. Advances
In this exclusive video from DDW 2016, Mark Pochapin, MD, from NYU Langone Medical Center, discusses Gastro Girl, a new online platform that provides support to patients with chronic gastrointestinal symptoms and conditions.
It’s no secret that one of the biggest things holding New York City’s biotech ecosystem back is lack of lab space for startups. The problem will take a broad effort to solve, not just a few buildings or incubators. But one of the city’s biggest real estate players, Alexandria Real Estate Equities, has announced a plan today to help out.
The Maryland Department of Commerce is joining with the state’s top research universities and other life sciences partners and stakeholders to create two or more Centers of Excellence around the state to support cell, gene and regenerative therapies, as well as medical devices and 3-D printing. This partnership with The Johns Hopkins University, the University of Maryland, Baltimore and the University of Maryland, College Park will help position Maryland as a leader in commercialization and clinical translation of next-generation medicines and medical devices and ensure the state remains a leader in healthcare innovation. Additional partners include the Center for Medical Technology Policy and biotechnology, pharmaceutical, contract manufacturing, and medical device companies.
Gaithersburg-based Novavax Inc. plans to create up to 850 new jobs as part of its planned Montgomery County expansion and will receive state and county financial assistance to support the growth, it was announced Wednesday.
The next Kendall Square just might be located in Allston.
The gritty Boston neighborhood, across the Charles from Harvard University’s main campus, is the site of various construction projects aimed at building up an innovation epicenter over the next five to 10 years. Just don’t tell Jodi Goldstein about the Kendall comparison.
Longitude Capital, an investment firm focused on venture growth investments in biotechnology and medical technology, closed its third fund, at $525m in partner commitments.
The Kansas City, Mo.-based Kauffman Foundation recently released its 2016 Kauffman Index of Growth Entrepreneurship and found — to the authors seeming surprise — that the Washington, D.C. metro area topped a list of U.S. metro areas with the most growth entrepreneurship.
Three experts explain synthetic biology and discuss its potential to affect fields as varied as medicine, oil, agriculture, and even fragrances.